These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 19377412)
1. Infection versus innate immunity in septic shock. Del Sorbo L; Fanelli V Minerva Anestesiol; 2009 Sep; 75(9):482-3. PubMed ID: 19377412 [No Abstract] [Full Text] [Related]
2. Therapeutic approaches to innate immunity: severe sepsis and septic shock. Lolis E; Bucala R Nat Rev Drug Discov; 2003 Aug; 2(8):635-45. PubMed ID: 12904813 [No Abstract] [Full Text] [Related]
3. A new hypothesis: treatment of septic shock by provoking a mild infection simultaneously. Halabe Bucay A Med Hypotheses; 2009 Nov; 73(5):854-5. PubMed ID: 19477077 [No Abstract] [Full Text] [Related]
4. Correlation of traumatic shock with immunocompetence and sepsis. Baker CC; Miller CL; Trunkey DD Surg Forum; 1979; 30():20-1. PubMed ID: 538594 [No Abstract] [Full Text] [Related]
5. Sepsis and innate immunity. Shasby DM; McCray P Am J Respir Crit Care Med; 2004 Jan; 169(2):144-5. PubMed ID: 14718231 [No Abstract] [Full Text] [Related]
9. Septic shock. Nichols D Crit Care Clin; 2010 Apr; 26(2):xiii-xiv. PubMed ID: 20381717 [No Abstract] [Full Text] [Related]
10. [Practical management of toxic states in infants: diagnosis and treatment. II]. Prişcu R; Maiorescu M; Pop M; Salzberg N; Făgărăşanu G; Iordăchescu F Pediatria (Bucur); 1968; 17(2):169-78. PubMed ID: 5669072 [No Abstract] [Full Text] [Related]
11. [Immunological parameters in diabetic patients with septic shock]. Lukach VN; Mal'kov OA; Girsh AO Anesteziol Reanimatol; 2008; (3):35-8. PubMed ID: 18652170 [TBL] [Abstract][Full Text] [Related]
12. Influence of innate cytokine production capacity on clinical manifestation and severity of pediatric meningococcal disease. Sprong T; van der Ven-Jongekrijg J; Neeleman C; van der Meer JW; van Deuren M Crit Care Med; 2009 Oct; 37(10):2812-8. PubMed ID: 19707127 [TBL] [Abstract][Full Text] [Related]
13. [Endogenous opioid peptides in septic shock]. Sierra Camerino R Med Clin (Barc); 1993 Oct; 101(11):437. PubMed ID: 8231361 [No Abstract] [Full Text] [Related]
14. The use of immunocompromised animals as models for human septic shock. Opal SM; Cross AS Shock; 2005 Dec; 24 Suppl 1():64-70. PubMed ID: 16374375 [TBL] [Abstract][Full Text] [Related]
17. The role of macrophages in septic shock. Evans TJ Immunobiology; 1996 Oct; 195(4-5):655-9. PubMed ID: 8933164 [No Abstract] [Full Text] [Related]
18. Septic shock. Badoe EA Afr J Med Med Sci; 1993 Dec; 22(4):1-4. PubMed ID: 7839923 [No Abstract] [Full Text] [Related]
19. [Advances in septic shock]. Martínez Carrasco MC; García García S; de la Oliva P; Ruza F An Esp Pediatr; 1988 Sep; 29 Suppl 33():154-7. PubMed ID: 3074690 [No Abstract] [Full Text] [Related]
20. Survival or death from sepsis. Clowes GH Surgery; 1970 Feb; 67(2):374-82. PubMed ID: 5411306 [No Abstract] [Full Text] [Related] [Next] [New Search]